Literature DB >> 4271955

[Vinblastine + procarbazine + cyclophosphamide association in the treatment of Hodgkin's disease (author's transl)].

J Chauvergne, B Hoerni, G Hoerni-Simon, M Durand, C Lagarde.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4271955     DOI： 10.1007/bf00305134

Source DB:  PubMed          Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol        ISSN： 0084-5353


× No keyword cloud information.
  4 in total

1.  [Therapeutic trial in disseminated Hodgkin's disease (stages 3 and IV) by sequence chemotherapy, radiotherapy, eventually associated with splenectomy and supplementary chemotherapy].

Authors:  J L Amiel; M Schlienger; A Laugier; J Rouëssé; C Jasmin; M Hayat; M Tubiana; G Mathé
Journal:  Nouv Rev Fr Hematol       Date:  1970 Sep-Oct

2.  A randomized study of irradiation and vinblastine in stages I and II of Hodgkin's disease. Preliminary results.

Authors: 
Journal:  Eur J Cancer       Date:  1972-06       Impact factor: 9.162

3.  [Proposal for standardization of the appraisal of therapeutical results].

Authors:  J Chauvergne; B Hoerni
Journal:  Bord Med       Date:  1971-05

4.  [Chemotherapy of Hodgkin's disease with therapeutic associations].

Authors:  C Jacquillat; M Weil; J P Desprez-Curély; J Tanzer; M F Gemon; R Blouin; F Teillet; J Delobel; J P Loisel; M Boiron; J Bernard
Journal:  Bull Cancer       Date:  1971 Apr-Jun       Impact factor: 1.276
  4 in total
  1 in total

1.  Influence of dose intensity and density on therapeutic and toxic effects in Hodgkin's disease.

Authors:  P Lagarde; F Bonichon; H Eghbali; I de Mascarel; J Chauvergne; B Hoerni
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.